Position in BMY
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$4,336,711
-$231,568 QoQ
Shares Held
75,264
-0.1% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.38%
of 13F equity value
Holder Rank
#585
of 2,506 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026DELTA ASSET MANAGEMENT LLC/TN holds $27,667,664 across 14 Drug Manufacturers - General names. BMY ranks #3 (15.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
40,142 | $10,194,863 | |
| 2 | ABBV |
AbbVie Inc.
|
30,429 | $7,657,153 | |
| 3 | BMY |
Bristol Myers Squibb Co
This page
|
75,264 | $4,336,711 | |
| 4 | PFE |
Pfizer Inc
|
105,462 | $2,539,524 | |
| 5 | MRK |
Merck & Co., Inc.
|
12,334 | $1,584,919 | |
| 6 | LLY |
ELI LILLY & Co
|
671 | $804,817 | |
| 7 | AMGN |
Amgen Inc
|
999 | $361,757 | |
| 8 | GSK |
GSK plc
|
2,138 | $112,073 |
All Filings in BMY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,336,711 | 75,264 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $4,568,279 | 75,322 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $4,112,331 | 76,239 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $3,373,389 | 74,798 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $3,408,934 | 73,643 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $4,606,208 | 75,524 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $4,372,427 | 77,306 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $4,117,262 | 79,576 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $3,395,534 | 81,761 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $4,683,357 | 86,361 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $3,974,677 | 77,464 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $4,177,487 | 71,976 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $4,501,184 | 70,386 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $4,665,533 | 67,314 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $4,627,895 | 64,321 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $4,571,584 | 64,307 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $4,940,089 | 64,157 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $4,776,088 | 65,399 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $4,095,272 | 65,682 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $3,962,259 | 66,964 | Shares | Sole | 2021-11-03 | |
| 2021-06-30 | $4,421,145 | 66,165 | Shares | Sole | 2021-08-02 | |
| 2021-03-31 | $4,140,254 | 65,583 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $3,711,316 | 59,831 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $3,466,373 | 57,495 | Shares | Sole | 2020-10-28 | |
| 2020-06-30 | $3,264,399 | 55,517 | Shares | Sole | 2020-07-23 | |
| 2020-03-31 | $2,939,225 | 52,731 | Shares | Sole | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||